Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β1-Adrenergic Receptors.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of the American College of Cardiology

• Publication date

  2017-02-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacc.2016.11.067PMID 28231950PMCID PMC5330212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.

  2016cited by this paper
• β1-Adrenoceptor Autoantibodies from DCM Patients Enhance the Proliferation of T Lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK Pathways

  2012cited by this paper
• Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization

  2012cited by this paper
• Administration of the cyclic peptide COR‐1 in humans (phase I study): ex vivo measurements of anti‐β1‐adrenergic receptor antibody neutralization and of immune parameters

  2012cited by this paper
• Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy

  2011cited by this paper
• Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study.

  2011cited by this paper
• Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure.

  2010influential reference
• A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure.

  2009influential reference
• Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009.

  2009influential reference
• Autoantigen Estimation and Simple Screening Assay Against Cardiodepressant Autoantibodies in Patients With Dilated Cardiomyopathy

  2008cited by this paper
• The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.

  2008cited by this paper
• Prediction of Cardiac Stability After Weaning From Left Ventricular Assist Devices in Patients With Idiopathic Dilated Cardiomyopathy

  2008cited by this paper
• Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy.

  2007cited by this paper
• Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.

  2006cited by this paper
• Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces early afterdepolarization and decreases in K-channel density in rabbits.

  2004cited by this paper
• Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.

  2004cited by this paper
• Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

  2004cited by this paper
• Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.

  2004cited by this paper
• Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes.

  2003cited by this paper
• Specific Removal of β1-Adrenergic Autoantibodies from Patients with Idiopathic Dilated Cardiomyopathy

  2002cited by this paper
• Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates.

  2002cited by this paper
• Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy.

  2002influential reference
• Potential Role of Autoantibodies Belonging to the Immunoglobulin G-3 Subclass in Cardiac Dysfunction Among Patients With Dilated Cardiomyopathy

  2002cited by this paper
• Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes.

  2001cited by this paper
• beta(1)-Adrenoceptor antibodies induce positive inotropic response in isolated cardiomyocytes.

  2001cited by this paper
• Autoimmunity Against the Second Extracellular Loop of &bgr;1-Adrenergic Receptors Induces &bgr;-Adrenergic Receptor Desensitization and Myocardial Hypertrophy In Vivo

  2001cited by this paper
• Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy.

  2001influential reference
• Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies.

  2000cited by this paper
• A Monoclonal Antibody Directed Against an Autoimmune Epitope on the Human β1-Adrenergic Receptor Recognized in Idiopathic Dilated Cardiomyopathy

  2000cited by this paper
• Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.

  1999cited by this paper
• Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease.

  1999cited by this paper
• Probing the immunological properties of the extracellular domains of the human beta(1)-adrenoceptor.

  1999cited by this paper
• Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes.

  1998cited by this paper
• Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52

  1998cited by this paper
• Agonistic Anti-β1-Adrenergic Receptor Autoantibodies From Cardiomyopathy Patients Reduce the β1-Adrenergic Receptor Expression in Neonatal Rat Cardiomyocytes

  1998cited by this paper
• Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose.

  1997influential reference
• Antibody-mediated imbalance of myocardial energy metabolism. A causal factor of cardiac failure?

  1995cited by this paper
• Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops.

  1995cited by this paper
• A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

  1995cited by this paper
• Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect.

  1994cited by this paper
• Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy.

  1992cited by this paper
• Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.

  1990cited by this paper
• Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.

  1989cited by this paper
• Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies

  1987cited by this paper

• Frequency of autoantibodies and their associated clinical characteristics and outcomes in patients with dilated cardiomyopathy: A systematic review and meta-analysis.

  2025cites this paper
• Autoimmunity in Cardiomyopathy-Induced Heart Failure and Cardiac Autoantibody Removal by Immunoadsorption

  2025cites this paper
• Prognostic value of β1 adrenergic receptor autoantibodies for microvascular obstruction in patients with STEMI with Post-PCI: A prospective cohort study

  2024influential citation
• Targeting anti-CXCR3 autoantibodies as potential cardioprotective therapy: promises and challenges.

  2023cites this paper
• Autoantibodies against the chemokine receptor 3 predict cardiovascular risk

  2023cites this paper
• β1 Adrenergic Receptor Autoantibodies and IgG Subclasses: Current Status and Unsolved Issues

  2023influential citation
• Epac1 participates in β1-adrenoreceptor autoantibody-mediated decreased autophagic flux in cardiomyocytes.

  2023cites this paper
• Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure

  2023influential citation
• Biology of myocardial recovery in advanced heart failure with long-term mechanical support.

  2022cites this paper
• Influence of β1 Adrenergic Receptor Genotype on Longitudinal Measures of Left Ventricular Ejection Fraction and Responsiveness to ß-Blocker Therapy in Patients With Duchenne Muscular Dystrophy

  2022cites this paper
• Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies

  2022cites this paper
• The IgG3 subclass of β1-adrenergic receptor autoantibodies is an endogenous biaser of β1AR signaling

  2021cites this paper
• Biased activation of β2-AR/Gi/GRK2 signal pathway attenuated β1-AR sustained activation induced by β1-adrenergic receptor autoantibody

  2021cites this paper
• The IgG3 Subclass of β1-adrenergic receptor autoantibody is an endogenous biaser of β1AR signaling

  2020influential citation
• β1-Adrenoreceptor Autoantibodies in Heart Failure: Physiology and Therapeutic Implications.

  2020cites this paper
• Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis

  2020cites this paper
• Mechanical Assist Devices and Heart Transplantation

  2020cites this paper
• Restraint stress induces uterine microenvironment disorder in mice during early pregnancy through the β2-AR/cAMP/PKA pathway

  2020cites this paper
• Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome

  2019cites this paper
• Diagnostic and prognostic value of autoantibodies against β1-adrenoreceptors in patients with heart failure following acute myocardial infarction: A 5-year prospective study

  2019cites this paper
• Immune Modulation in Heart Failure: the Promise of Novel Biologics

  2018cites this paper
• Influence of Beta-1 Adrenergic Receptor Genotype on Cardiovascular Response to Exercise in Healthy Subjects

  2018cites this paper
• Beta-1-Adrenergic Receptor Antibodies in Acute Coronary Syndrome: Is Less Sometimes More?

  2018cites this paper
• Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors—a requisite for correct data evaluation

  2018influential citation
• &bgr;2-adrenergic receptor autoantibodies alleviated myocardial damage induced by &bgr;1-adrenergic receptor autoantibodies in heart failure

  2018cites this paper
• Difference between beta1-adrenoceptor autoantibodies of human and animal origin—Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology

  2018cites this paper
• Autoantibodies Directed Against the β1-Adrenergic Receptor in Patients With Dilated Cardiomyopathy.

  2017cites this paper
• cardiomyopathy: n ¼ 6; long QT syndrome: n syndrome

  2017influential citation
• Reply: Understanding Subclass Diversity of Detectable β1-Adrenergic Receptor Autoantibodies and their Clinical Impact.

  2017cites this paper
• The β1-Adrenergic Receptor IgG Subclass 3 Autoantibody in Dilated Cardiomyopathy: Friend or Foe?

  2017cites this paper
• β1AAb Determined by Peptide ELISA: A Signal in the Noise?

  2017cites this paper